Home » Topics » Regulatory » Patents

Patents
RSS

Agents for depression and related disorders from American Home Products

June 24, 1997

Hypocholesterolemic compounds reported by Schering-Plough

June 23, 1997

Monoamine reuptake inhibitors disclosed by NeuroSearch

June 23, 1997

Merck Frosst prepares prodrugs of COX-2 inhibitors

June 23, 1997

Anti-HBV nucleosides from Chong Kun Dang

June 23, 1997

Novel immunosuppressants prepared by Merck & Co.

June 20, 1997

Merck & Co. discloses muscarinic antagonists for myopia

June 20, 1997

Agents for glaucoma revealed by Merck & Co.

June 20, 1997

NicOx reveals antiinflammatory/antithrombotic compounds with low toxicity

June 20, 1997

Agents for psoriasis and cancers from Roche

June 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...